These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8807886)

  • 21. Structural studies of porcine myeloid antibacterial peptide PMAP-23 and its analogues in DPC micelles by NMR spectroscopy.
    Park K; Oh D; Shin SY; Hahm KS; Kim Y
    Biochem Biophys Res Commun; 2002 Jan; 290(1):204-12. PubMed ID: 11779154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial peptide protegrin-3 adopt an antiparallel dimer in the presence of DPC micelles: a high-resolution NMR study.
    Usachev KS; Efimov SV; Kolosova OA; Klochkova EA; Aganov AV; Klochkov VV
    J Biomol NMR; 2015 May; 62(1):71-9. PubMed ID: 25786621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androctonin, a novel antimicrobial peptide from scorpion Androctonus australis: solution structure and molecular dynamics simulations in the presence of a lipid monolayer.
    Mandard N; Sy D; Maufrais C; Bonmatin JM; Bulet P; Hetru C; Vovelle F
    J Biomol Struct Dyn; 1999 Oct; 17(2):367-80. PubMed ID: 10563585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-sheet antibiotic peptides as potential dental therapeutics.
    Miyasaki KT; Lehrer RI
    Int J Antimicrob Agents; 1998 Feb; 9(4):269-80. PubMed ID: 9573496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial and conformational studies of the active and inactive analogues of the protegrin-1 peptide.
    Rodziewicz-Motowidło S; Mickiewicz B; Greber K; Sikorska E; Szultka L; Kamysz E; Kamysz W
    FEBS J; 2010 Feb; 277(4):1010-22. PubMed ID: 20074208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression and structural study of the cathelicidin motif of the protegrin-3 precursor.
    Sanchez JF; Wojcik F; Yang YS; Strub MP; Strub JM; Van Dorsselaer A; Martin M; Lehrer R; Ganz T; Chavanieu A; Calas B; Aumelas A
    Biochemistry; 2002 Jan; 41(1):21-30. PubMed ID: 11771999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structure of porcine protegrin genes.
    Zhao C; Ganz T; Lehrer RI
    FEBS Lett; 1995 Jul; 368(2):197-202. PubMed ID: 7628604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of the antimicrobial beta-hairpin peptide protegrin-1 in a DLPC lipid bilayer investigated by molecular dynamics simulation.
    Khandelia H; Kaznessis YN
    Biochim Biophys Acta; 2007 Mar; 1768(3):509-20. PubMed ID: 17254546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The solution structure and activity of caerin 1.1, an antimicrobial peptide from the Australian green tree frog, Litoria splendida.
    Wong H; Bowie JH; Carver JA
    Eur J Biochem; 1997 Jul; 247(2):545-57. PubMed ID: 9266696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophenin-1, an exceptionally proline-rich antimicrobial peptide from porcine leukocytes.
    Harwig SS; Kokryakov VN; Swiderek KM; Aleshina GM; Zhao C; Lehrer RI
    FEBS Lett; 1995 Mar; 362(1):65-9. PubMed ID: 7698355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of disulfide bridges in the 3-D structures of the antimicrobial peptides gomesin and protegrin-1: a molecular dynamics study.
    Castro JR; Fuzo CA; Degrève L; Caliri A
    Genet Mol Res; 2008 Oct; 7(4):1070-88. PubMed ID: 19048486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins.
    Kokryakov VN; Harwig SS; Panyutich EA; Shevchenko AA; Aleshina GM; Shamova OV; Korneva HA; Lehrer RI
    FEBS Lett; 1993 Jul; 327(2):231-6. PubMed ID: 8335113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMR structure of mussel mytilin, and antiviral-antibacterial activities of derived synthetic peptides.
    Roch P; Yang Y; Toubiana M; Aumelas A
    Dev Comp Immunol; 2008; 32(3):227-38. PubMed ID: 17628674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphate-mediated arginine insertion into lipid membranes and pore formation by a cationic membrane peptide from solid-state NMR.
    Tang M; Waring AJ; Hong M
    J Am Chem Soc; 2007 Sep; 129(37):11438-46. PubMed ID: 17705480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial potency and selectivity of simplified symmetric-end peptides.
    Dong N; Zhu X; Chou S; Shan A; Li W; Jiang J
    Biomaterials; 2014 Sep; 35(27):8028-39. PubMed ID: 24952979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of protegrins against yeast-phase Candida albicans.
    Cho Y; Turner JS; Dinh NN; Lehrer RI
    Infect Immun; 1998 Jun; 66(6):2486-93. PubMed ID: 9596706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QSAR analysis of antimicrobial and haemolytic effects of cyclic cationic antimicrobial peptides derived from protegrin-1.
    Frecer V
    Bioorg Med Chem; 2006 Sep; 14(17):6065-74. PubMed ID: 16714114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational study of the protegrin-1 (PG-1) dimer interaction with lipid bilayers and its effect.
    Jang H; Ma B; Nussinov R
    BMC Struct Biol; 2007 Apr; 7():21. PubMed ID: 17407565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of protegrin-1 with lipid bilayers: membrane thinning effect.
    Jang H; Ma B; Woolf TB; Nussinov R
    Biophys J; 2006 Oct; 91(8):2848-59. PubMed ID: 16861271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oligomerization of protegrin-1 in the presence of DPC micelles. A proton high-resolution NMR study.
    Roumestand C; Louis V; Aumelas A; Grassy G; Calas B; Chavanieu A
    FEBS Lett; 1998 Jan; 421(3):263-7. PubMed ID: 9468319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.